EURACTIV PR

An easy way of publishing your relevant EU press releases.

SGIs Network Joint Declaration for the Tripartite Social Summit of 20 March 2024

The SGIs Network gathers associati

PostEurop’s Input to the ERGP Work Programme 2025

PostEurop welcomes the call for input regarding the ERGP Work Programme 2025. This is the  opportunity to make a contribution to ERGP’s work and to bring out the main issues to tackle in  the postal sector. The postal sector still finds itself in volatile times in which volumes are negatively  impacted by the worldwide macroeconomic and geopolitical developments, resulting in record-high  inflation and decreasing consumer trust.

PostEurop’s Input to the EC Prospective Postal Study – Comments on 5 scenarios

1. Introduction 

PostEurop welcomes the opportunity to contribute to the design of future scenarios for the  Postal sector. 

PostEurop Letter to DG GROW on e-commerce

Brussels, 6 March 2024

 

Ref: EFR,BS/024/6/jv

Customer satisfaction related findings of the IPC Cross-Border E-Commerce Shopper Survey 2022 PostEurop comments on the ERGP Report on the application of the Cross-Border Parcel Regulation

 

Dear Ms Clausen,

By means of this communication, PostEurop would like to share with you interesting and important

customer satisfaction related findings of the IPC Cross-Border E-Commerce Shopper Survey 2022

Standing Ovation joins EuropaBio: Animal Free Dairy Through Precision Fermentation

Brussels, 25 March 2024 - EuropaBio is very happy to announce that Standing Ovation has joined as a member.

As a French company founded in Paris in 2020, Standing Ovation uses precision fermentation to produce caseins that can be used to create lactose free cheese and dairy products without requiring intensive animal breeding.

Standing Ovation aims to facilitate the food transition by boosting EU food security through a complementary source of casein protein, and paving the way for a new era of dairy products with a lower environmental impact.

Renforcer les budgets participatifs : leçons pour l'engagement inclusif, la transparence et l'efficacité

Le budget participatif (BP) se révèle être une approche prometteuse pour renforcer l'engagement des citoyens dans la gouvernance locale et les processus de prise de décision. Grâce à cette approche, les citoyens ont la possibilité d'influencer directement la manière dont les fonds publics sont alloués et de donner la priorité aux projets qui répondent aux besoins de leur communauté. Cependant, comme pour toute nouvelle initiative, il y a des défis à relever et des leçons à tirer.

EcoVadis, WindEurope and leading wind industry organisations launch ‘Wind Energy Initiative’

Today, EcoVadis, WindEurope and five leading wind energy industry organisations - ENGIE, Hitachi Energy, Siemens Gamesa, Statkraft and Vestas – announce the launch of the ‘Wind Energy Initiative’. The Initiative aims to accelerate the uptake of sustainable practices by fostering strong collaboration between trading partners and amplifying positive impacts across their value chains.

European politicians, citizens and businesses want reliable, affordable and clean energy. Wind energy is a local, competitive, and scalable resource that can provide that energy.

Rebound in wind energy financing in 2023 shows that the right policies attract investors

Investments in wind energy in Europe more than doubled in 2023 compared to 2022, driven by record financing of offshore wind projects.

Conservatives and liberals join forces with far right against small investors, undermining the capital markets union

The Socialists and Democrats deplore a harmful deal on the Retail Investment Strategy brokered by conservative and liberal forces in the European Parliament in collaboration with the far right. Yesterday, the European Parliament’s committee on economic affairs voted in favour of the compromise proposed by the liberal rapporteur Stéphanie Yon-Courtin, which will seriously harm small investors and undermine the capital markets union.

European Commission Biotech initiative must spearhead next wave of EU biosimilar advances for patients and stimulate manufacturing

Date of release: 20 March 2024

Biosimilar medicines were invented in Europe over 15 years ago. Since then, they have increased patient access to essential biologic medicines needed to treat the most serious of diseases like cancer, autoimmune conditions and diabetes by well over 50%.  

Pages

Subscribe to EURACTIV PR RSS